License Required
Retacrit® Epoetin Alfa-epbx 40,000 U/mL Injection for Anemia Treatment
00069130904 | USAMP#12465307
container type
volume
dosage form
strength
Secure Checkout
Verified Supply Chain
Priority Fulfillment
More Information
Locked
Base Price
$3,025.83
CT
🎯 Unlock Your Custom Tiered Price
15-35% bulk discounts
100+
units
10% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
250+
units
20% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
500+
units
30% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
Unlock Bulk Pricing
See pricing for all volume tiers
Instant access to volume pricing. Register free to compare all tiers and calculate your exact savings.
5,000+ verified buyers
Average savings:$23,400/year
15-35% OFF
for healthcare facilities on bulk orders
24/7 Live Chat!
Instant support anytime
Product Spotlight
- High-potency Retacrit® Epoetin Alfa-epbx 40,000 U/mL Injection for effective anemia management.
- Single-dose 1 mL vial designed for ease of use and minimal waste.
- Manufactured by Pfizer Biosimilar, ensuring pharmaceutical quality and reliability.
- Formulated for subcutaneous or intravenous administration, providing flexibility in clinical application.
- Requires refrigeration to maintain stability and efficacy of the medication.
- Latex-free packaging to minimize allergic reactions and ensure patient safety.
- An essential hematopoietic agent for patients with chronic kidney disease, chemotherapy-induced anemia, or HIV-related anemia.
